Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.14 EUR | 0.00% | +1.79% | -12.98% |
03-29 | Laboratorio Farmaceutico Erfo, revenues grow and profit remains stable | AN |
02-19 | Mib in the red at 31,600; TIM still on top | AN |
Sales 2023 * | 6.3M 6.79M 9.29M | Sales 2024 * | 6.5M 7.01M 9.58M | Capitalization | 10.26M 11.06M 15.13M |
---|---|---|---|---|---|
Net income 2023 * | - 0 0 | Net income 2024 * | - 0 0 | EV / Sales 2023 * | 1.37 x |
Net cash position 2023 * | 1.6M 1.72M 2.36M | Net cash position 2024 * | 2M 2.16M 2.95M | EV / Sales 2024 * | 1.27 x |
P/E ratio 2023 * |
12.7
x | P/E ratio 2024 * |
19
x | Employees | 29 |
Yield 2023 * |
-
| Yield 2024 * |
-
| Free-Float | 22.6% |
1 week | +1.79% | ||
Current month | +1.79% | ||
1 month | -2.15% | ||
3 months | +14.00% | ||
6 months | +18.75% | ||
Current year | -12.98% |
Managers | Title | Age | Since |
---|---|---|---|
Flavio Corpina
CEO | Chief Executive Officer | 45 | 16-12-31 |
Alessandro Cutè
CEO | Chief Executive Officer | 53 | 12-12-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Alessandro Cutè
CEO | Chief Executive Officer | 53 | 12-12-31 |
Flavio Corpina
CEO | Chief Executive Officer | 45 | 16-12-31 |
Fabio Giuffre
BRD | Director/Board Member | 43 | - |
Date | Price | Change | Volume |
---|---|---|---|
24-05-09 | 1.14 | +1.33% | 8,000 |
24-05-08 | 1.125 | -0.44% | 7,000 |
24-05-07 | 1.13 | +0.44% | 7,000 |
24-05-06 | 1.125 | -2.17% | 4,000 |
24-05-03 | 1.15 | +0.88% | 17,000 |
Real-time Borsa Italiana, May 09, 2024 at 11:44 am
More quotesEPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-12.98% | 10.88M | |
+32.36% | 698B | |
+26.51% | 568B | |
-4.40% | 358B | |
+19.46% | 328B | |
+3.50% | 283B | |
+16.34% | 238B | |
+6.68% | 203B | |
-9.08% | 198B | |
+8.62% | 165B |
- Stock Market
- Equities
- ERFO Stock